Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
2.610
+0.070 (2.76%)
At close: May 16, 2025, 4:00 PM
2.570
-0.040 (-1.54%)
After-hours: May 16, 2025, 7:58 PM EDT
Akebia Therapeutics Market Cap
Akebia Therapeutics has a market cap or net worth of $685.48 million as of May 16, 2025. Its market cap has increased by 159.85% in one year.
Market Cap
685.48M
Enterprise Value
767.70M
1-Year Change
159.85%
Ranking
Category
Stock Price
$2.61
Market Cap Chart
Since March 20, 2014, Akebia Therapeutics's market cap has increased from $488.10M to $685.48M, an increase of 40.44%. That is a compound annual growth rate of 3.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2025 | 667.10M | 60.94% |
| Dec 31, 2024 | 414.50M | 77.44% |
| Dec 29, 2023 | 233.60M | 120.17% |
| Dec 30, 2022 | 106.10M | -73.17% |
| Dec 31, 2021 | 395.40M | -2.30% |
| Dec 31, 2020 | 404.70M | -46.16% |
| Dec 31, 2019 | 751.70M | 138.26% |
| Dec 31, 2018 | 315.50M | -55.11% |
| Dec 29, 2017 | 702.90M | 76.17% |
| Dec 30, 2016 | 399.00M | 0.81% |
| Dec 31, 2015 | 395.80M | 67.15% |
| Dec 31, 2014 | 236.80M | -51.49% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.94B |
| Johnson & Johnson | 364.11B |
| AbbVie | 325.05B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 264.80B |
| Abbott Laboratories | 234.53B |
| Novartis AG | 213.43B |
| AstraZeneca | 212.39B |